Genetic Test May Allow for Personalized ADHD Medications

Many parents are reluctant to medicate their children with ADHD

Many parents are reluctant to medicate their children with ADHD

A new test that looks at three genes may allow doctors to know which medication would be most effective for which child suffering from ADHD.

This new test, called GeneSightRx ADHD, was created by AssureRx Health to help reduce the number of different medications and side effects patients may experience before finding the appropriate medication to manage their ADHD. The test is part of a broader trend in the pharmaceutical industry toward personalized medications.

Attention Deficit Hyperactivity Disorder (ADHD) diagnoses increased 66 percent from 6.2 million in 2000 to 10.4 million in 2010, according to a recent study published in the March/April 2012 issue of Academic Pediatrics.

Despite the prevalence of ADHD, many parents are reluctant to put their children on medication.

“Parents are often resistant to putting their child on an ADHD medication because of the trial and error factor. Will it work? They don’t want to put their child through the often stressful, lengthy and expensive process of trying multiple medications,” says Jeanine Miles, a parent of a child with ADHD, a Licensed Professional Counselor (LPC), and the director of business development at the CFG Health Network.

Recognizing this dilemma, Center for Family Guidance, the outpatient behavioral healthcare division of the New Jersey-based CFG Health Network, looked to a new, innovative technology that aids clinicians in quickly finding the most appropriate level of care.

Patients now have the option of taking an ADHD-specific pharmacogenomic test that analyzes a patient’s unique genomic profile to determine how they may respond to different medications.

A simple cotton cheek swab provides sufficient DNA to analyze three genes that influence how a patient metabolizes certain medications used to treat ADHD in children and adults. The GeneSightRx ADHD report of a patient’s unique genetic profile then helps Center for Family Guidance clinicians individualize a patient’s medication selection.

Read the rest of this story at New Test to Help ADHD Patients Quickly Find an Effective Medication.

PrintFriendly and PDF

Switch to our mobile site